Pastilles overtake oil among 18-44 age group as SAS-B approvals near 2024 total by Steve Jones October 1, 2025October 1, 2025 Pastilles have overtaken oil as the second most prescribed dosage form among the 18-44 age demographic, […]
Montu calls for single prescriber framework in TGA submission by Adam Sheldon August 28, 2025August 28, 2025
May SAS-B approvals slip from April record but still close to 20,000 by Steve Jones June 3, 2025June 3, 2025
SAS-B approvals hit all-time high in April as Tasmania spikes again by Steve Jones May 2, 2025May 2, 2025
SAS-B approvals hit second highest on record as Tassie shows surprise growth by Steve Jones April 2, 2025April 2, 2025
Two-month total of SAS-B approvals up 47% on 2024, TGA data shows by Steve Jones March 4, 2025April 1, 2025
Growth of pastilles accelerates as SAS approvals get off to strong start in 2025 by Steve Jones February 17, 2025February 17, 2025
Pastilles continue steady SAS-B growth but flower retains top spot by Steve Jones December 4, 2024April 11, 2025
Patients left in limbo as TGA knocks back vape battery applications by Steve Jones November 20, 2024November 21, 2024
NSW SAS-B approvals below annual average following crackdown by Steve Jones October 2, 2024October 2, 2024
